People who took hydroxychloroquine in combination with another drug while hospitalized with COVID-19 were less likely to die than those who didn’t, according to a new study.
Hydroxychloroquine, which is widely used against malaria and arthritis, was given to hundreds of patients hospitalized with COVID-19 in Belgium. Thousands of others didn’t receive the drug.





